Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 193 Lymphoid 82 Myeloid 33 Plasma cell 8 Sarcoma 2 Classical hematology 2 Tumor-Agnostic 1 Other neoplasm 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 197 Bevacizumab 164 Fluorouracil 153 Gemcitabine 137 Capecitabine 137 Leucovorin 110 pembrolizumab 102 Cisplatin 98 Drug Therapy 90 Irinotecan 79 Radiotherapy 73 sintilimab 70 130-nm albumin-bound paclitaxel 68 durvalumab 67 Paclitaxel 65 Cetuximab 64 Specimen Handling 62 tislelizumab 60 lenvatinib 60 Magnetic Resonance Spectroscopy 57 Folfox protocol 56 Nivolumab 54 Blood Specimen Collection 52 Biopsy 48 atezolizumab 47 Surgical Procedures, Operative 40 Taxes 39 Albumin-Bound Paclitaxel 39 Immune Checkpoint Inhibitors 37 HMPL-013 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × venetoclax × Gastrointestinal × Clear all

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡